{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T21:03:21Z","timestamp":1780002201918,"version":"3.53.1"},"reference-count":240,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003824","name":"Hunan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2025YFC2311703"],"award-info":[{"award-number":["2025YFC2311703"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.virs.2026.03.011","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:25:55Z","timestamp":1774599955000},"page":"261-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2818-0432","authenticated-orcid":false,"given":"Lei","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.03.011_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132155","article-title":"Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination","volume":"5","author":"Abreu","year":"2020","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.virs.2026.03.011_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pathol.2025.06.011","article-title":"Epidemiology of respiratory syncytial virus within a new South Wales-based multicentre health district between 2018 and 2024 in Australia","volume":"58","author":"Akhtar","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.virs.2026.03.011_bib3","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1038\/s41598-020-79590-7","article-title":"Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses","volume":"11","author":"Allen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.03.011_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0166-0934(87)90081-4","article-title":"Studies on the attenuation of the Sabin type 3 oral polio vaccine","volume":"17","author":"Almond","year":"1987","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virs.2026.03.011_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1473-3099(24)00215-9","article-title":"Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study","volume":"24","author":"Ares-G\u00f3mez","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70134","article-title":"Genetic evolution of the hemagglutinin genes of seasonal influenza A viruses in Turkiye between 2017 and 2023","volume":"19","author":"Azbazdar","year":"2025","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib7","doi-asserted-by":"crossref","first-page":"11151","DOI":"10.1021\/acs.jpcb.4c04607","article-title":"Molecular dynamics investigation of the influenza hemagglutinin conformational changes in acidic pH","volume":"128","author":"Badiee","year":"2024","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.virs.2026.03.011_bib8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chom.2019.04.003","article-title":"Influenza antigen engineering focuses immune responses to a subdominant but broadly protective viral epitope","volume":"25","author":"Bajic","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virs.2026.03.011_bib9","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1016\/j.vaccine.2024.03.070","article-title":"Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18-49 years of age: results of a randomized phase 3 study","volume":"42","author":"Baker","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib10","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib11","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1038\/s41564-024-01860-1","article-title":"A foldon-free prefusion F trimer vaccine for respiratory syncytial virus to reduce off-target immune responses","volume":"9","author":"Bakkers","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib12","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1038\/s41467-024-50659-5","article-title":"Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer","volume":"15","author":"Bakkers","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib13","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1021\/acs.jpcb.5b02582","article-title":"Conformational transition in signal transduction: metastable states and transition pathways in the activation of a signaling protein","volume":"119","author":"Banerjee","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.virs.2026.03.011_bib14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","article-title":"A site of vulnerability on the influenza virus Hemagglutinin head domain trimer interface","volume":"177","author":"Bangaru","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.03.011_bib15","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/s41467-018-04704-9","article-title":"A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA","volume":"9","author":"Bangaru","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1473-3099(22)00525-4","article-title":"Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study","volume":"23","author":"Bardsley","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41579-019-0149-x","article-title":"Respiratory syncytial virus entry and how to block it","volume":"17","author":"Battles","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib18","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1006\/viro.2002.1497","article-title":"Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment","volume":"298","author":"Bego\u00f1a Ruiz-Arg\u00fcello","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.03.011_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/145.3.311","article-title":"Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial","volume":"145","author":"Belshe","year":"1982","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz8822","article-title":"Structural monitoring of a transient intermediate in the hemagglutinin fusion machinery on influenza virions","volume":"6","author":"Benhaim","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virs.2026.03.011_bib21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41586-020-2333-6","article-title":"Structural transitions in influenza haemagglutinin at membrane fusion pH","volume":"583","author":"Benton","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib23","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/infdis\/jiy065","article-title":"Safety and immunogenicity of 3 formulations of an investigational respiratory syncytial virus vaccine in nonpregnant women: results from 2 phase 2 trials","volume":"217","author":"Beran","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib25","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/irv.12998","article-title":"International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: association with school closures","volume":"16","author":"Billard","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib26","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/INF.0b013e31821fef9e","article-title":"Commentary: why are young healthy term infants protected against respiratory syncytial virus bronchiolitis?","volume":"30","author":"Bont","year":"2011","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.virs.2026.03.011_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159709","article-title":"Structure-based design of head-only fusion glycoprotein immunogens for respiratory syncytial virus","volume":"11","author":"Boyington","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.03.011_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41541-019-0126-4","article-title":"A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains","volume":"4","author":"Broecker","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1126\/science.1225416","article-title":"Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses","volume":"337","author":"Burton","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib30","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1128\/JVI.00057-15","article-title":"Influenza hemagglutinin (HA) stem region mutations that stabilize or destabilize the structure of multiple HA subtypes","volume":"89","author":"Byrd-Leotis","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41541-024-00959-0","article-title":"Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine","volume":"9","author":"Casazza","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41579-019-0282-6","article-title":"Neisseria meningitidis: using genomics to understand diversity, evolution and pathogenesis","volume":"18","author":"Caugant","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib33","doi-asserted-by":"crossref","first-page":"eade0424","DOI":"10.1126\/scitranslmed.ade0424","article-title":"A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine","volume":"14","author":"Chang","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11262-022-01904-w","article-title":"An overview of influenza A virus genes, protein functions, and replication cycle highlighting important updates","volume":"58","author":"Chauhan","year":"2022","journal-title":"Virus Genes"},{"key":"10.1016\/j.virs.2026.03.011_bib35","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/1744666X.2025.2494658","article-title":"Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review","volume":"21","author":"Chaumont","year":"2025","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/irv.70054","article-title":"Changes in respiratory syncytial virus-associated hospitalisations epidemiology after nirsevimab introduction in Lyon, France","volume":"18","author":"Chauvel","year":"2024","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade6422","article-title":"Rational design of a highly immunogenic prefusion-stabilized F glycoprotein antigen for a respiratory syncytial virus vaccine","volume":"15","author":"Che","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib38","article-title":"Gamma irradiation-inactivated respiratory syncytial virus vaccine provides protection but exacerbates pulmonary inflammation by switching from prefusion to postfusion F protein","volume":"11","author":"Chen","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virs.2026.03.011_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0092-8674(00)81771-7","article-title":"Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation","volume":"95","author":"Chen","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.03.011_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41587-023-02120-z","article-title":"What does it take for an 'AlphaFold Moment' in functional protein engineering and design?","volume":"42","author":"Chica","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2026.03.011_bib41","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01463-22","article-title":"Single particle analysis of H3N2 influenza entry differentiates the impact of the sialic acids (Neu5Ac and Neu5Gc) on virus binding and membrane fusion","volume":"97","author":"Chien","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib42","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1080\/21645515.2021.1885280","article-title":"A review of the BCG vaccine and other approaches toward tuberculosis eradication","volume":"17","author":"Cho","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virs.2026.03.011_bib43","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/bmj.1.1951.1312","article-title":"The milroy lectures on the natural history of vaccinia: delivered at the royal college of physicians","volume":"1","author":"Copeman","year":"1898","journal-title":"Br. Med. J."},{"key":"10.1016\/j.virs.2026.03.011_bib44","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/IAI.69.11.7130-7139.2001","article-title":"Activity and cross-reactivity of antibodies induced in mice by immunization with a group B meningococcal conjugate","volume":"69","author":"Coquillat","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virs.2026.03.011_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02810-18","article-title":"Design of nanoparticulate group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.virs.2026.03.011_bib46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature12442","article-title":"Cross-neutralization of four paramyxoviruses by a human monoclonal antibody","volume":"501","author":"Corti","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib48","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coviro.2017.03.002","article-title":"Tackling influenza with broadly neutralizing antibodies","volume":"24","author":"Corti","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003831","article-title":"A single amino acid in the stalk region of the H1N1pdm influenza virus HA protein affects viral fusion, stability and infectivity","volume":"10","author":"Cotter","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib50","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cell.2018.05.050","article-title":"Direct visualization of the conformational dynamics of single influenza hemagglutinin trimers","volume":"174","author":"Das","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.03.011_bib51","doi-asserted-by":"crossref","first-page":"11561","DOI":"10.1128\/JVI.76.22.11561-11569.2002","article-title":"Immunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infection","volume":"76","author":"De Swart","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib52","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/vaccines3010105","article-title":"M2e-Based universal influenza A vaccines","volume":"3","author":"Deng","year":"2015","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.03.011_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","article-title":"Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses","volume":"9","author":"Deng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib54","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1172\/JCI84428","article-title":"Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection","volume":"126","author":"Dilillo","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virs.2026.03.011_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"Dilillo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib56","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1172\/JCI136032","article-title":"Anti-influenza H7 human antibody targets antigenic site in hemagglutinin head domain interface","volume":"130","author":"Dong","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.virs.2026.03.011_bib57","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tibtech.2008.08.002","article-title":"Structure-based antigen design: a strategy for next generation vaccines","volume":"26","author":"Dormitzer","year":"2008","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.virs.2026.03.011_bib58","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-024-03431-7","article-title":"Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults","volume":"31","author":"Du","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib59","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","article-title":"Cross-neutralization of influenza A viruses mediated by a single antibody loop","volume":"489","author":"Ekiert","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib60","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1038\/s41467-024-48601-w","article-title":"A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramer","volume":"15","author":"Fan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib61","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2316964120","article-title":"Protective human antibodies against a conserved epitope in pre- and postfusion influenza hemagglutinin","volume":"121","author":"Finney","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202729","article-title":"Nanovaccines displaying the influenza virus hemagglutinin in an inverted orientation elicit an enhanced stalk-directed antibody response","volume":"12","author":"Frey","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.virs.2026.03.011_bib63","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.virs.2024.09.002","article-title":"A multi-center study on genetic variations in the fusion protein of respiratory syncytial virus from children with acute lower respiratory tract infections in China during 2017-2021","volume":"39","author":"Fu","year":"2024","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2026.03.011_bib64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12967-025-07673-y","article-title":"B-cell epitope prediction in the age of machine learning: advancements and challenges","volume":"24","author":"Gabellieri","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009062","article-title":"Structural intermediates in the low pH-induced transition of influenza hemagglutinin","volume":"16","author":"Gao","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib66","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208011119","article-title":"Reversible structural changes in the influenza hemagglutinin precursor at membrane fusion pH","volume":"119","author":"Garcia-Moro","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib67","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41590-025-02286-5","article-title":"Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy","volume":"26","author":"Gieselmann","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib68","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aaj1879","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors","volume":"1","author":"Gilman","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib69","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/s41467-019-09807-5","article-title":"Transient opening of trimeric prefusion RSV F proteins","volume":"10","author":"Gilman","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib70","doi-asserted-by":"crossref","first-page":"9859","DOI":"10.1073\/pnas.151098198","article-title":"Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion","volume":"98","author":"Gonz\u00e1lez-Reyes","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coi.2015.04.005","article-title":"Novel antigens for RSV vaccines","volume":"35","author":"Graham","year":"2015","journal-title":"Curr. Opin. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.virs.2026.03.011_bib72","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/irv.12081","article-title":"Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010","volume":"7","author":"Group","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib73","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib74","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41579-023-00945-8","article-title":"Co-evolution of immunity and seasonal influenza viruses","volume":"21","author":"Han","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib76","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/JVI.02790-15","article-title":"Identification of stabilizing mutations in an H5 Hemagglutinin influenza virus protein","volume":"90","author":"Hanson","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/08927020701361876","article-title":"Evaluating the stability of disulfide bridges in proteins: a torsional potential energy surface for diethyl disulfide","volume":"33","author":"Haworth","year":"2007","journal-title":"Mol. Simul."},{"key":"10.1016\/j.virs.2026.03.011_bib78","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","article-title":"Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies","volume":"23","author":"Haynes","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib79","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib80","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10900-009-9187-z","article-title":"Smallpox. The death of a disease. The inside story of eradicating a worldwide killer","volume":"35","author":"Imperato","year":"2010","journal-title":"J. Community Health"},{"key":"10.1016\/j.virs.2026.03.011_bib82","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S2213-2600(25)00048-7","volume":"13","author":"Ison","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib83","doi-asserted-by":"crossref","first-page":"W533","DOI":"10.1093\/nar\/gkae386","article-title":"Sema 2.0: web-platform for B-cell conformational epitopes prediction using artificial intelligence","volume":"52","author":"Ivanisenko","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virs.2026.03.011_bib84","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/exd.12925","article-title":"An inquiry into the causes and effects of the variolae (or cow-pox. 1798)","volume":"25","author":"Jenson","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.virs.2026.03.011_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1086297","article-title":"Analysis of the conserved protective epitopes of hemagglutinin on influenza A viruses","volume":"14","author":"Jiao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib185","first-page":"123","article-title":"On the earliest Chinese record of 1522 on inoculation against smallpox and the legends on its inventor","author":"Jiang","year":"2008","journal-title":"Stud. Hist. Nat. Sci."},{"key":"10.1016\/j.virs.2026.03.011_bib86","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/JVI.72.4.2871-2880.1998","article-title":"Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge","volume":"72","author":"Johnson","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007944","article-title":"Alternative conformations of a major antigenic site on RSV F","volume":"15","author":"Jones","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib88","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nsmb.3267","article-title":"Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV","volume":"23","author":"Joyce","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virs.2026.03.011_bib89","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.1128\/JVI.01532-14","article-title":"Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene","volume":"88","author":"Kamlangdee","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib90","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib91","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib92","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virs.2026.03.011_bib93","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3389\/fimmu.2019.00684","article-title":"Immunology's coming of age","volume":"10","author":"Kaufmann","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib94","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41541-024-00987-w","article-title":"Recombinant RSV G protein vaccine induces enhanced respiratory disease via IL-13 and mucin overproduction","volume":"9","author":"Kawahara","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib95","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/v10080446","article-title":"The morphology and assembly of respiratory syncytial virus revealed by cryo-electron tomography","volume":"10","author":"Ke","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib96","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s40265-022-01829-6","article-title":"Nirsevimab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.virs.2026.03.011_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/srep34108","article-title":"Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus","volume":"6","author":"Killikelly","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.03.011_bib98","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ijmm.2004.07.008","article-title":"Genome-based vaccines","volume":"294","author":"Knaust","year":"2004","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.virs.2026.03.011_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib100","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s44222-025-00349-8","article-title":"AI-driven protein design","volume":"3","author":"Koh","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.virs.2026.03.011_bib101","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028845","article-title":"Is it possible to develop a \"Universal\" influenza virus vaccine? Potential target antigens and critical aspects for a universal influenza vaccine","volume":"10","author":"Krammer","year":"2018","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.virs.2026.03.011_bib102","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib103","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/JVI.07158-11","article-title":"Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses","volume":"86","author":"Krause","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.70575","article-title":"A morphological transformation in respiratory syncytial virus leads to enhanced complement deposition","volume":"10","author":"Kuppan","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.virs.2026.03.011_bib105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nm.2071","article-title":"Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming","volume":"16","author":"Kwakkenbos","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib106","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.immuni.2018.04.029","article-title":"HIV-1 vaccines based on antibody identification, B cell ontogeny, and epitope structure","volume":"48","author":"Kwong","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.03.011_bib107","series-title":"Stabilized Pre-fusion Rsv Fb Antigens","author":"Langedijk","year":"2022"},{"key":"10.1016\/j.virs.2026.03.011_bib108","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1038\/s41467-024-54287-x","article-title":"Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory syncytial virus and metapneumovirus","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib109","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/infdis\/jiac327","article-title":"Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase 1\/2 randomized clinical trial","volume":"227","author":"Leroux-Roels","year":"2023","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/infdis\/jiad321","article-title":"Safety and immunogenicity of a revaccination with a respiratory syncytial virus prefusion F vaccine in older adults: a phase 2b study","volume":"229","author":"Leroux-Roels","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib111","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1002\/eji.200939532","article-title":"Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display","volume":"39","author":"Li","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005418","article-title":"Acidic pH-Induced conformations and LAMP1 binding of the Lassa virus glycoprotein spike","volume":"12","author":"Li","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib113","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.1038\/s41467-022-32926-5","article-title":"Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib114","first-page":"1","article-title":"Innovation amidst post-socialist reform: Jonas salk and the birth of the Sabin strains-derived inactivated polio vaccine in China","author":"Li","year":"2025","journal-title":"Br. J. Hist. Sci."},{"key":"10.1016\/j.virs.2026.03.011_bib115","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/s41586-023-06762-6","article-title":"HIV-1 Env trimers asymmetrically engage CD4 receptors in membranes","volume":"623","author":"Li","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib116","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.03.011_bib117","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.adp2362","article-title":"Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation","volume":"385","author":"Liang","year":"2024","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.virs.2026.03.011_bib118","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.3390\/ijms23084341","article-title":"Identification of B-Cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting","volume":"23","author":"Lim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virs.2026.03.011_bib119","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2510163122","article-title":"Structural insights into VRC01-class bnAb precursors with diverse light chains elicited in the IAVI G001 human vaccine trial","volume":"122","author":"Lin","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142240","article-title":"Soluble influenza H3 trimer proteins enhance the breadth and potency of antibody response","volume":"307","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virs.2026.03.011_bib121","series-title":"Structure-Based Design of a Broadly Protective Influenza Hemagglutinin Stem Immunogen","author":"Liu","year":"2024"},{"key":"10.1016\/j.virs.2026.03.011_bib122","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2389095","article-title":"Disulfide-stabilized trimeric hemagglutinin ectodomains provide enhanced heterologous influenza protection","author":"Liu","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2026.03.011_bib123","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1038\/s41467-022-31840-0","article-title":"Human-type sialic acid receptors contribute to avian influenza A virus binding and entry by hetero-multivalent interactions","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib124","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fimmu.2019.00756","article-title":"Sequential immunization with live-attenuated chimeric hemagglutinin-based vaccines confers heterosubtypic immunity against influenza A viruses in a preclinical ferret model","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib125","article-title":"A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses","volume":"122","author":"Liu","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib126","first-page":"8","article-title":"A recombinant mosaic HAs influenza vaccine elicits broad-spectrum immune response and protection of influenza a viruses","volume":"12","author":"Liu","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.03.011_bib127","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41541-023-00728-5","article-title":"A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses","volume":"8","author":"Liu","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib128","article-title":"Mosaic hemagglutinin-based whole inactivated virus vaccines induce broad protection against influenza B virus challenge in mice","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib129","article-title":"Sub-neutralizing levels of antibodies against RSV F protein enhance RSV infection via Fc-Fc\u03b3R interactions","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib130","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib131","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/d41586-024-02513-3","article-title":"The pathogens that could spark the next pandemic","volume":"632","author":"Mallapaty","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.011_bib132","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0167-7799(00)89014-9","article-title":"Louis Pasteur (1822-1895)--chance and the prepared mind","volume":"13","author":"Manchester","year":"1995","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.virs.2026.03.011_bib133","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo3153","article-title":"Intermediates in SARS-CoV-2 spike-mediated cell entry","volume":"8","author":"Marcink","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virs.2026.03.011_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008883","article-title":"Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces","volume":"16","author":"Marcink","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib135","doi-asserted-by":"crossref","first-page":"6660","DOI":"10.1016\/j.vaccine.2018.09.056","article-title":"Antigenic and sequence variability of the human respiratory syncytial virus F glycoprotein compared to related viruses in a comprehensive dataset","volume":"36","author":"Mas","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib136","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fimmu.2019.00751","article-title":"The development of a vaccine against Meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib137","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/vaccines8010132","article-title":"Development of next generation Streptococcus pneumoniae vaccines conferring broad protection","volume":"8","author":"Masomian","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.03.011_bib138","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.1038\/s41467-025-60232-3","article-title":"Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses","volume":"16","author":"Matthys","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib139","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.immuni.2017.12.009","article-title":"Memory B cells that cross-react with group 1 and group 2 influenza A viruses are abundant in adult human repertoires","volume":"48","author":"Mccarthy","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.03.011_bib140","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00929-23","article-title":"Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope","volume":"97","author":"Mccool","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib141","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2015.03.002","article-title":"Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein","volume":"11","author":"Mclellan","year":"2015","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib142","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"Mclellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib143","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"Mclellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib144","first-page":"83","article-title":"Structure and function of respiratory syncytial virus surface glycoproteins","volume":"372","author":"Mclellan","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib145","doi-asserted-by":"crossref","first-page":"7788","DOI":"10.1128\/JVI.00555-11","article-title":"Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes","volume":"85","author":"Mclellan","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib146","doi-asserted-by":"crossref","first-page":"793","DOI":"10.15585\/mmwr.mm7229a4","article-title":"Use of respiratory syncytial virus vaccines in older adults: recommendations of the advisory committee on immunization practices - united States, 2023","volume":"72","author":"Melgar","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.virs.2026.03.011_bib147","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115379119","article-title":"Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions","volume":"119","author":"Milder","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib148","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3390\/vaccines13060649","article-title":"Expanded programme on immunization (EPI): a legacy of 50 years and the road ahead","volume":"13","author":"Mirza","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virs.2026.03.011_bib149","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.immuni.2022.10.015","article-title":"Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses","volume":"55","author":"Moin","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.03.011_bib150","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciz803","article-title":"Lessons from influenza pandemics of the last 100 years","volume":"70","author":"Monto","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib151","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tim.2017.09.004","article-title":"Predictive modeling of influenza shows the promise of applied evolutionary biology","volume":"26","author":"Morris","year":"2018","journal-title":"Trends Microbiol."},{"issue":"12","key":"10.1016\/j.virs.2026.03.011_bib152","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.050011","article-title":"Louis Pasteur continues to shape the future of microbiology","volume":"15","author":"Mostowy","year":"2022","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.virs.2026.03.011_bib153","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1128\/jcm.24.5.894-898.1986","article-title":"Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection","volume":"24","author":"Murphy","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib154","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1128\/jcm.26.8.1595-1597.1988","article-title":"Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity","volume":"26","author":"Murphy","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib155","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib156","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1146\/annurev-med-120617-041310","article-title":"Is a universal influenza virus vaccine possible?","volume":"71","author":"Nachbagauer","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib157","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.str.2024.05.001","article-title":"Structural basis for the broad antigenicity of the computationally optimized influenza hemagglutinin X6","volume":"32","author":"Nagashima","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.virs.2026.03.011_bib158","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0165-5728(90)90146-E","article-title":"Evidence for autoimmune antibodies directed against embryonic neural cell adhesion molecules (N-CAM) in patients with group B meningitis","volume":"29","author":"Nedelec","year":"1990","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.virs.2026.03.011_bib159","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2416628122","article-title":"Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens","volume":"122","author":"Nguyen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib161","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/pathogens10111352","article-title":"Next-generation computationally designed influenza hemagglutinin vaccines protect against H5Nx virus infections","volume":"10","author":"Nunez","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.virs.2026.03.011_bib162","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1128\/JVI.05397-11","article-title":"Naturally occurring antibodies in humans can neutralize a variety of influenza virus strains, including H3, H1, H2, and H5","volume":"85","author":"Ohshima","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101127","article-title":"SARS-CoV-2 S2P spike ages through distinct states with altered immunogenicity","volume":"297","author":"Olia","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virs.2026.03.011_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-1900-1_1","article-title":"Vaccine design by reverse vaccinology and machine learning","volume":"2414","author":"Ong","year":"2022","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virs.2026.03.011_bib165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02284-17","article-title":"Evaluation of preexisting anti-hemagglutinin stalk antibody as a correlate of protection in a healthy volunteer challenge with influenza A\/H1N1pdm virus","volume":"9","author":"Park","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.virs.2026.03.011_bib166","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1038\/s41467-023-40878-7","article-title":"Structure-based design of a strain transcending AMA1-RON2L malaria vaccine","volume":"14","author":"Patel","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib167","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/v17060798","article-title":"Analysis of epidemiological and evolutionary characteristics of seasonal influenza viruses in Shenzhen city from 2018 to 2024","volume":"17","author":"Peng","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib168","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1021\/acsinfecdis.5c00368","article-title":"Structural basis for postfusion-specific binding to the respiratory syncytial virus F protein by the canonical antigenic site I antibody 131-2a","volume":"11","author":"Peng","year":"2025","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib169","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrmicro.2017.146","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj7843","article-title":"Fatal enhanced respiratory syncytial virus disease in toddlers","volume":"13","author":"Polack","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib171","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib172","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41591-023-02571-6","volume":"29","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib173","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virs.2026.03.011_bib174","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fchem.2019.00889","article-title":"Residual dipolar couplings for resolving cysteine bridges in disulfide-rich peptides","volume":"7","author":"Ramanujam","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.virs.2026.03.011_bib175","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","article-title":"Reverse vaccinology","volume":"3","author":"Rappuoli","year":"2000","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib176","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib177","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41541-024-00952-7","article-title":"Sequential immunization with chimeric hemagglutinin \u0394NS1 attenuated influenza vaccines induces broad humoral and cellular immunity","volume":"9","author":"Rathnasinghe","year":"2024","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib178","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1073\/pnas.1715471115","article-title":"Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody","volume":"115","author":"Raymond","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1346619","article-title":"The greatest contribution to medical science is the transformation from studying symptoms to studying their causes-the unrelenting legacy of Robert Koch and Louis Pasteur-and a causality perspective to approach a definition of SLE","volume":"15","author":"Rekvig","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib180","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1016\/S2214-109X(24)00135-9","article-title":"Respiratory syncytial virus seasonality in China: implications for intervention","volume":"12","author":"Ren","year":"2024","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.virs.2026.03.011_bib181","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jsb.2016.06.017","article-title":"Native structure of a retroviral envelope protein and its conformational change upon interaction with the target cell","volume":"197","author":"Riedel","year":"2017","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.virs.2026.03.011_bib182","first-page":"21","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"SAVE Proc."},{"key":"10.1016\/j.virs.2026.03.011_bib183","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.immuni.2019.08.007","article-title":"Immunological lessons from respiratory syncytial virus vaccine development","volume":"51","author":"Ruckwardt","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.03.011_bib184","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1099\/vir.0.80318-0","article-title":"Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism","volume":"85","author":"Ruiz-Arg\u00fcello","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib186","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.320661","article-title":"Control of influenza and poliomyelitis with killed virus vaccines","volume":"195","author":"Salk","year":"1977","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib187","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0140-6736(24)01016-X","article-title":"50 years of the expanded programme on immunization","volume":"403","author":"Samarasekera","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.03.011_bib188","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12985-017-0918-y","article-title":"Towards a universal influenza vaccine: different approaches for one goal","volume":"15","author":"Sautto","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.virs.2026.03.011_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114811","article-title":"Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies","volume":"43","author":"Scharffenberger","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2026.03.011_bib190","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02180-16","article-title":"Immunization with low doses of recombinant postfusion or prefusion respiratory syncytial virus F primes for vaccine-enhanced disease in the cotton rat model independently of the presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) adjuvant","volume":"91","author":"Schneider-Ohrum","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib191","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40259-013-0034-5","article-title":"Genome-based bacterial vaccines: current state and future outlook","volume":"27","author":"Schubert-Unkmeir","year":"2013","journal-title":"BioDrugs"},{"key":"10.1016\/j.virs.2026.03.011_bib192","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1038\/s41598-021-88537-5","article-title":"Surveillance of respiratory syncytial virus infections in adults, Austria, 2017 to 2019","volume":"11","author":"Schubert","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.03.011_bib193","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/infdis\/jiz395","article-title":"Immunogenicity and safety of 3 formulations of a respiratory syncytial virus candidate vaccine in nonpregnant women: a phase 2, randomized trial","volume":"220","author":"Schwarz","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.011_bib194","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.vaccine.2009.01.072","article-title":"Genome-based approaches to develop vaccines against bacterial pathogens","volume":"27","author":"Serruto","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib195","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay5051","article-title":"De novo protein design enables the precise induction of RSV-neutralizing antibodies","volume":"368","author":"Sesterhenn","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib196","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.immuni.2010.09.017","article-title":"Reverse vaccinology: developing vaccines in the era of genomics","volume":"33","author":"Sette","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.virs.2026.03.011_bib197","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.03.011_bib198","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","article-title":"Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin","volume":"69","author":"Skehel","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.virs.2026.03.011_bib199","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2739\/kurumemedj.52.111","article-title":"Pioneering figures in medicine: Albert Bruce Sabin--inventor of the oral polio vaccine","volume":"52","author":"Smith","year":"2005","journal-title":"Kurume Med. J."},{"key":"10.1016\/j.virs.2026.03.011_bib200","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1016\/j.vaccine.2017.08.021","article-title":"Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M\u2122 adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes","volume":"35","author":"Smith","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.147116","article-title":"Identification and characterization of linear B cell epitopes of monoclonal antibodies against the S2 subunit of porcine deltacoronavirus","volume":"323","author":"Song","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virs.2026.03.011_bib202","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213332120","article-title":"In situ architecture and membrane fusion of SARS-CoV-2 Delta variant","volume":"120","author":"Song","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib203","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1603732","article-title":"BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond","volume":"13","author":"Starshinova","year":"2025","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.virs.2026.03.011_bib204","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128779","article-title":"A cysteine zipper stabilizes a pre-fusion F glycoprotein vaccine for respiratory syncytial virus","volume":"10","author":"Stewart-Jones","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.03.011_bib205","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2352-4642(25)00093-8","article-title":"Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis","volume":"9","author":"Sumsuzzman","year":"2025","journal-title":"Lancet Child Adolesc. Health"},{"key":"10.1016\/j.virs.2026.03.011_bib206","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00333-19","article-title":"Development of influenza B universal vaccine candidates using the \"Mosaic\" hemagglutinin approach","volume":"93","author":"Sun","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib207","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105785","article-title":"Broadly neutralizing antibodies to combat influenza virus infection","volume":"221","author":"Sun","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.03.011_bib208","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba6466","article-title":"A respiratory syncytial virus (RSV) F protein nanoparticle vaccine focuses antibody responses to a conserved neutralization domain","volume":"5","author":"Swanson","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.virs.2026.03.011_bib209","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.1106536108","article-title":"Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers","volume":"108","author":"Swanson","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2026.03.011_bib210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib211","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2514357","article-title":"Respiratory syncytial virus (RSV) infections in adults: current trends and recommendations for prevention - a global challenge from a local perspective","volume":"21","author":"Tanriover","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virs.2026.03.011_bib212","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50832","article-title":"Estimated vaccine effectiveness for respiratory syncytial virus-related lower respiratory tract disease","volume":"7","author":"Tartof","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.virs.2026.03.011_bib213","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fcimb.2020.00225","article-title":"Respiratory syncytial virus's non-structural proteins: masters of interference","volume":"10","author":"Thornhill","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103281","article-title":"Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis","volume":"84","author":"Trusinska","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.virs.2026.03.011_bib215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2014.03.015","article-title":"Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins","volume":"185","author":"Vasin","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.virs.2026.03.011_bib216","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41541-025-01273-z","article-title":"AI-driven epitope prediction: a systematic review, comparative analysis, and practical guide for vaccine development","volume":"10","author":"Villanueva-Flores","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib217","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0140-6736(24)00982-6","article-title":"Expanded programme on immunization at 50 years: its legacy and future","volume":"403","author":"Wahl","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.03.011_bib218","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1080\/22221751.2022.2109515","article-title":"Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein","volume":"11","author":"Wang","year":"2022","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2026.03.011_bib219","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.abn2100","article-title":"Scaffolding protein functional sites using deep learning","volume":"377","author":"Wang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.011_bib220","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2506288","article-title":"Cost-effectiveness analysis of nirsevimab for prevention of respiratory syncytial virus disease among infants in Shanghai, China: a modeling study","volume":"21","author":"Wang","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virs.2026.03.011_bib221","doi-asserted-by":"crossref","first-page":"15183","DOI":"10.1074\/jbc.RA120.014466","article-title":"HIV-cell membrane fusion intermediates are restricted by Serincs as revealed by cryo-electron and TIRF microscopy","volume":"295","author":"Ward","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virs.2026.03.011_bib222","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","article-title":"Antibodies to a conserved influenza head interface Epitope protect by an IgG subtype-dependent mechanism","volume":"177","author":"Watanabe","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.03.011_bib223","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/pharmaceutics12090848","article-title":"Preclinical progress of subunit and live attenuated Mycobacterium tuberculosis vaccines: a review following the first in human efficacy trial","volume":"12","author":"Watt","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.virs.2026.03.011_bib224","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virs.2026.03.011_bib225","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1128\/IAI.71.8.4633-4641.2003","article-title":"Functional selection of vaccine candidate peptides from Staphylococcus aureus whole-genome expression libraries in vitro","volume":"71","author":"Weichhart","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virs.2026.03.011_bib226","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2016.272","article-title":"Structural basis for antibody cross-neutralization of respiratory syncytial virus and human metapneumovirus","volume":"2","author":"Wen","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virs.2026.03.011_bib227","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade4790","article-title":"An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults","volume":"15","author":"Widge","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib228","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s42256-024-00971-y","article-title":"Deep learning enhances the prediction of HLA class I-presented CD8(+) T cell epitopes in foreign pathogens","volume":"7","author":"Wohlwend","year":"2025","journal-title":"Nat. Mach. Intell."},{"key":"10.1016\/j.virs.2026.03.011_bib229","doi-asserted-by":"crossref","first-page":"7372","DOI":"10.1016\/j.vaccine.2007.08.014","article-title":"The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines","volume":"25","author":"Wright","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib230","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.jmb.2017.06.015","article-title":"A perspective on the structural and functional constraints for immune evasion: insights from influenza virus","volume":"429","author":"Wu","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virs.2026.03.011_bib231","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038778","article-title":"Influenza hemagglutinin structures and antibody recognition","volume":"10","author":"Wu","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib232","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.cell.2019.04.034","article-title":"\"Breathing\" hemagglutinin reveals cryptic epitopes for universal influenza vaccine design","volume":"177","author":"Wu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.03.011_bib233","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41589-023-01529-6","article-title":"Vaccine design via antigen reorientation","volume":"20","author":"Xu","year":"2024","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.virs.2026.03.011_bib234","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1002\/jmv.26779","article-title":"Neutralizing antibody PR8-23 targets the footprint of the sialoglycan receptor binding site of H1N1 hemagglutinin","volume":"93","author":"Yan","year":"2021","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virs.2026.03.011_bib235","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.011_bib236","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41541-025-01178-x","article-title":"Chimeric hemagglutinin and M2 mRNA vaccine for broad influenza subtype protection","volume":"10","author":"Yi","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virs.2026.03.011_bib237","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000350","article-title":"Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses","volume":"5","author":"Yoshida","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.03.011_bib238","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41467-025-67778-2","article-title":"Integrating protein language and geometric deep learning models for enhanced vaccine antigen prediction","volume":"17","author":"Zai","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.011_bib239","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3390\/v11070628","article-title":"The optimal concentration of formaldehyde is key to stabilizing the pre-fusion conformation of respiratory syncytial virus fusion protein","volume":"11","author":"Zhang","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.03.011_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126882","article-title":"Development and evaluation of mosaic VLPs vaccine for enhanced broad-spectrum immunity against influenza B virus lineages in mice","volume":"51","author":"Zhao","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.virs.2026.03.011_bib241","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj1928","article-title":"A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants","volume":"9","author":"Zhu","year":"2017","journal-title":"Sci. Transl. Med."}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:19:41Z","timestamp":1779999581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26000489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":240,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1995820X26000489"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.03.011","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural vaccinology expedites rational design of next-generation vaccines for influenza and respiratory syncytial virus","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}